Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Treats Adults

Martin M Zenni, MD

Interventional Cardiologist Nuclear Cardiologist

Interventional Cardiologist, Nuclear Cardiologist

Photo of Martin M Zenni

Research at a glance

Top areas of exploration

  • Platelet Aggregation Inhibitors , 28 publications
  • Clopidogrel , 20 publications
  • Platelet Aggregation , 18 publications
  • Coronary Artery Disease , 17 publications

Research activity

62 publications

1,794 citations

Why is this important?

My publications

62 publications

2023

Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.

JACC. Cardiovascular interventions

PubMed Publisher's site

2023

Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

PubMed Publisher's site

2023

Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.

JACC. Cardiovascular interventions

PubMed Publisher's site

2023

Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.

Thrombosis and haemostasis

PubMed Publisher's site

2022

Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease.

European heart journal. Cardiovascular pharmacotherapy

PubMed Publisher's site